Reply

Affiliations

¹ Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.

Comment

Jagpreet Chhatwal. Clin Gastroenterol Hepatol. 2017 Nov.

. 2017 Nov;15(11):1815.

doi: 10.1016/j.cgh.2017.07.031. Epub 2017 Aug 3.

¹ Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Liver Center and Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts.

No abstract available

Comment on

Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.
Chhatwal J, He T, Hur C, Lopez-Olivo MA. Chhatwal J, et al. Clin Gastroenterol Hepatol. 2017 Jun;15(6):827-837.e8. doi: 10.1016/j.cgh.2016.09.015. Epub 2016 Sep 17. Clin Gastroenterol Hepatol. 2017. PMID: 27650326
Societal Perspectives and Patient/Public Involvement in Direct-Acting Antiviral Agent Coverage of Hepatitis C Treatment in the United States.
Liu X, Lee JL, Yoo JW. Liu X, et al. Clin Gastroenterol Hepatol. 2017 Nov;15(11):1814-1815. doi: 10.1016/j.cgh.2017.06.009. Epub 2017 Jun 10. Clin Gastroenterol Hepatol. 2017. PMID: 28606844 No abstract available.